story of the week
Molecular Tools to Identify Ultra–Low Risk Patients With Indolent Breast Cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
JAMA Oncol 2017 Jun 29;[EPub Ahead of Print], LJ Esserman, C Yau, CK Thompson, LJ van 't Veer, AD Borowsky, KA Hoadley, NP Tobin, B Nordenskjöld, T Fornander, O Stål, CC Benz, LS LindströmFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.